ArticleOpen medicine (Warsaw, Poland)2025
Associated risk factors and prevalence of human papillomavirus infection among females visiting tertiary care hospital: a cross-sectional study from Nepal.
Article in Open medicine (Warsaw, Poland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: There is a greater risk of cervical neoplasia in women with ongoing cervical infections with high-risk human papillomaviruses. This study aimed to determine the prevalence and associated risk factors for human papillomavirus infection among females visiting tertiary care hospital. Methods: This cross-sectional study was conducted over seven months with 376 study participants. Cervical swab samples were collected, and HPV types were detected using polymerase chain reaction. The associated risk factors for HPV infection were analyzed via binary logistic regression analysis. Results: The mean age of the female participants was 38.98 ± 8.74 years. The majority of the participants were females aged 30-39 years. The overall HPV prevalence was 15.7 % (59/376), 37 % of which were HPV-16 and 20 % of which were HPV-18. Logistic regression revealed that the likelihood of contracting HPV infection was greater among married females (AOR 4.576) and who did not used contraceptive (condoms) (AOR 1.559). Conclusions: Our findings highlighted the notable prevalence of high-risk HPV-16 and HPV-18 and emphasized the importance of public awareness regarding risk factors of HPV infection, along with a specific emphasis on vaccination, promoting testing and early detection methods to curb the progression of cervical cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.